Raymond James & Associates »

Trevi Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $319k 95k 3.34
2024-06-30 $30k 10k 2.98
2024-03-31 $35k 10k 3.45